- Home
- SOWG vs ICCM Comparison
SOWG vs ICCM Comparison
Compare SOWG & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOWG | ICCM |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Packaged Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7M | 41.4M |
| IPO Year | 2011 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SOWG | ICCM |
|---|---|---|
| Price | $1.44 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 1.1M | 483.4K |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $0.25 |
| 52 Week High | $2.12 | $1.40 |
Technical Indicators
Market Signals| Indicator | SOWG | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 34.15 |
| Support Level | $0.40 | $0.26 |
| Resistance Level | $1.80 | $0.74 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 79.45 | 21.82 |
Price Performance
Historical ComparisonAbout SOWG Sow Good Inc.
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.